Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gaspar

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
JAMA Oncology|November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
The Lancet. Oncology|October 30, 2016
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyDaniel R Gomez, George R Blumenschein, J Jack Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain MetastasesPaul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Clinical and Translational Radiation Oncology|February 19, 2019
An <i>in-silico</i> quality assurance study of contouring target volumes in thoracic tumors within a cooperative group settingHesham Elhalawani, Baher Elgohari, Timothy A Lin, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
The Lancet. Oncology|June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 20, 2019
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?Paul W Sperduto, Penny Fang, Jing Li, et al.
Clinical and Translational Radiation Oncology|July 26, 2019
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)Paul W Sperduto, Penny Fang, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2020
Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to TodayPaul W Sperduto, Shane Mesko, Jing Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility QuotientPaul W Sperduto, Shane Mesko, Jing Li, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
JAMA Oncology|November 29, 2016
Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)Paul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
The Lancet. Oncology|October 30, 2016
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyDaniel R Gomez, George R Blumenschein, J Jack Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain MetastasesPaul W Sperduto, T Jonathan Yang, Kathryn Beal, et al.
Clinical and Translational Radiation Oncology|February 19, 2019
An <i>in-silico</i> quality assurance study of contouring target volumes in thoracic tumors within a cooperative group settingHesham Elhalawani, Baher Elgohari, Timothy A Lin, et al.
The Lancet. Oncology|September 3, 2013
Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
The Lancet. Oncology|June 13, 2015
Response assessment criteria for brain metastases: proposal from the RANO groupNancy U Lin, Eudocia Q Lee, Hidefumi Aoyama, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|March 20, 2019
Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?Paul W Sperduto, Penny Fang, Jing Li, et al.
Clinical and Translational Radiation Oncology|July 26, 2019
Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA)Paul W Sperduto, Penny Fang, Jing Li, et al.
International Journal of Radiation Oncology, Biology, Physics|February 22, 2020
Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to TodayPaul W Sperduto, Shane Mesko, Jing Li, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2020
Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility QuotientPaul W Sperduto, Shane Mesko, Jing Li, et al.
Pageof 20